TUESDAY, DECEMBER 6, 2016

VaxInnate Corporation

3 Cedar Brook Drive, Suite 1
Cranbury, NJ - 08512

VaxInnate Corporation News

Quadrivalent seasonal influenza vaccine candidate advances to Phase 2 testing

VaxInnate Corp., a biotechnology company creating a novel vaccine technology platform, recently announced that it has started a double-blind, randomized, active comparator controlled Phase 2 study for a quadrivalent seasonal influenza vaccine candidate. Read More »

VaxInnate adds to senior management team

Lynda Tussey promoted to chief scientific officer; three others join senior management Read More »